5 News & Press Releases found
Neovii Pharmaceuticals AG News
-
Neovii and Fosun Pharma Enter into an Exclusive Agreement
Neovii Pharmaceuticals AG (“Neovii”), a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical Industry Development Co. Ltd (“Fosun Pharma Industry”), a subsidiary of Shanghai Fosun ...
-
Leadership change and even more momentum: Biotech pioneer Neovii under new management
Dr. Christian Loss (57), former managing director of Neovii Biotech GmbH, Gräfelfing, is moving to the Swiss headquarters of Neovii Pharmaceuticals AG in Rapperswil as chief executive officer (CEO). As the new CEO in Germany, he will be ...
-
NEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine
Ramot, Tel Aviv University’s technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to ...
-
Neovii completes marketing authorisation withdrawal of Removab® in the European Union
At the request of Neovii Biotech GmbH, the European Commission withdrew the marketing authorisation for Removab® (catumaxomab) in the European Union (EU). Removab® was granted marketing authorisation in the EU on 20 April 2009 for treatment ...
-
Long-term outcomes after standard graft-versus-host disease
Neovii is pleased to announce the publication of the long-term outcomes of a multicenter parallel-group randomized trial conducted in Europe and Israel. The study looked at patients after standard GvHD prophylaxis with cyclosporine A and ...